Labcorp (LH)
(Real Time Quote from BATS)
$225.21 USD
+2.99 (1.35%)
Updated Sep 23, 2024 09:38 AM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Income Statements
Fiscal Year end for Labcorp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 12,162 | 14,877 | 16,121 | 13,979 | 11,555 |
Cost Of Goods | 8,797 | 10,492 | 10,497 | 9,026 | 8,302 |
Gross Profit | 3,365 | 4,385 | 5,624 | 4,953 | 3,253 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,639 | 2,611 | 2,365 | 2,507 | 1,922 |
Income After Depreciation & Amortization | 726 | 1,774 | 3,260 | 2,445 | 1,330 |
Non-Operating Income | 43 | -11 | 79 | -19 | 15 |
Interest Expense | 200 | 180 | 212 | 207 | 241 |
Pretax Income | 569 | 1,583 | 3,127 | 2,219 | 1,105 |
Income Taxes | 189 | 302 | 747 | 662 | 280 |
Minority Interest | 1 | 2 | 2 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 380 | 1,281 | 2,380 | 1,557 | 825 |
Extras & Discontinued Operations | 39 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 418 | 1,279 | 2,377 | 1,556 | 824 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,303 | 2,679 | 4,005 | 3,532 | 2,102 |
Depreciation & Amortization (Cash Flow) | 577 | 905 | 745 | 1,087 | 771 |
Income After Depreciation & Amortization | 726 | 1,774 | 3,260 | 2,445 | 1,330 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 87.60 | 91.60 | 97.50 | 98.00 | 98.60 |
Diluted EPS Before Non-Recurring Items | 13.56 | 19.94 | 28.52 | 23.94 | 11.32 |
Diluted Net EPS (GAAP) | 4.77 | 13.97 | 24.39 | 15.88 | 8.35 |
Fiscal Year end for Labcorp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 3,220.90 | 3,176.60 | 2,293.20 | 3,056.80 | 3,033.70 |
Cost Of Goods | 2,294.50 | 2,279.30 | 1,596.40 | 2,205.60 | 2,191.50 |
Gross Profit | 926.40 | 897.30 | 696.80 | 851.20 | 842.20 |
SG&A, R&D, and Dept/Amort Expenses | 631.60 | 576.00 | 830.80 | 598.90 | 575.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | 294.80 | 321.30 | -134.00 | 252.30 | 266.30 |
Non-Operating Income | 20.50 | 23.00 | 30.20 | 36.70 | -11.50 |
Interest Expense | 47.60 | 46.90 | 48.80 | 50.30 | 49.80 |
Pretax Income | 267.70 | 297.40 | -152.60 | 238.70 | 205.00 |
Income Taxes | 62.10 | 69.10 | 19.10 | 55.10 | 49.80 |
Minority Interest | 0.30 | 0.30 | 0.30 | 0.30 | 0.20 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 205.60 | 228.30 | -171.70 | 183.60 | 155.20 |
Extras & Discontinued Operations | 0.00 | 0.00 | 4.90 | 0.00 | 33.90 |
Net Income (GAAP) | 205.30 | 228.00 | -167.10 | 183.30 | 188.90 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 84.30 | 84.70 | 85.50 | 87.00 | 89.00 |
Diluted EPS Before Non-Recurring Items | 3.94 | 3.68 | 3.30 | 3.38 | 3.42 |
Diluted Net EPS (GAAP) | 2.43 | 2.69 | -1.85 | 2.11 | 2.12 |